Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Antibiotics for Burn Wound Grafting
NCT04516148Phase 4Completed
- Sponsor
- MedStar Health Research Institute
- Start
- May 2018
- Primary completion
- Oct 2020
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin, clindamycin in burn wound infection, sponsored by MedStar Health Research Institute. Started May 2018; status: completed.
02
Drugs
cefazolinclindamycin
03
Conditions
burn wound infection
Beyond the preview
Go deeper on NCT04516148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516148.